Versiti Blood Research Institute Michael Deininger was awarded $2.5M from NIH National Cancer Institute to study the role of tetraspanin MS4A in chronic myeloid #leukemia , including MS4A’s role as a new therapeutic. #CML #VersitiResearch

A 33 yrs old male patient named Yasir Khan Afridi is suffering from Myelodysplastic syndrome progressed to Acute Myeloid Leukemia. The patient is admitted at aga khan hospital karachi, Pakistan since 18th of May 2023.

Finding the right treatment when living with a health condition like chronic myeloid leukemia (CML) can be challenging. Learn how Al navigated his CML treatment journey and found the right fit for him.

#NovartisCollaborator

#chronicmyeloidleukemia #Cancer #Leukemia

It reached port ⛵! This paper started its journey in 2017 and, like an Iberian Caravel, got stuck in the pandemic doldrums. Thanks to all the crew (especially Kasia and Mainak) for rowing it to destination.
journals.aai.org/jimmunol/artic…

Fantastic talk from Mariam Hakobyan describing how mutant IDH1 hijacks differentiation programs in myeloid progenitors in AML.
#EHA23

A brave daughter from Pulwama, Mymoona Binti Ahad, is currently fighting a challenging battle against Acute Myeloid Leukemia (AML) Breast Cancer.

Appeal everyone to come forward and generously support the family.